Skip to main content
. 2023 May 9;13:20451253231171518. doi: 10.1177/20451253231171518

Table 1.

Descriptive statistics as a function of sample attrition.

Sample Percentage or mean SD n
Responders
 Mean age 52.8 13.8 608
 Female sex 80.6 608
 Mean number of strips 1.8 1.1 608
 Used Venlafaxine 41.3 608
 Used paroxetine 23.7 608
 Risk factors
  Fear withdrawal a 40.0 608
  Previous unsuccessful attempt 52.5 608
  Possible relapse 6.7 608
  Slow metaboliser b 1.7 608
  High dose c 3.1 608
  Problems when starting 2.7 608
  Problems when missing dose 8.1 608
  Antidepressant use > 2 years 81.1 608
  No risk factors 6.9 608
 Mean number of risk factors 1.9 1.0 608
Non-responders
 Mean age 46.5 15.4 3301
 Female sex 72.1 3301
 Mean number of strips 2.2 1.6 3301
 Used venlafaxine 37.0 3301
 Used paroxetine 18.9 3301
 Risk factors
  Fear withdrawal a 35.0 3301
  Previous unsuccessful attempt 44.9 3301
  Possible relapse 5.8 3301
  Slow metaboliser b 1.2 3301
  High dose c 2.4 3301
  Problems when starting 4.2 3301
  Problems when missing dose 8.8 3301
  Use longer than 2 years 71.2 3221
  No risk factors 14.4 3301
 Mean number of risk factors 1.7 1.1 3301
a

Fear of starting with medication reduction because of anticipated withdrawal.

b

Patient has undergone pharmacogenetic test indicating slow/intermediate metaboliser status for current medication.

c

Dose above maximum dose as recommended in the Dutch standard (Farmacotherapeutisch Kompas).